Pibutidine

Drug Profile

Pibutidine

Alternative Names: IT 066

Latest Information Update: 07 Aug 2007

Price : $50

At a glance

  • Originator Ikedo Mohando; Taisho Pharmaceutical
  • Class Antihistamines; Antiulcers; Gastric antisecretories; Piperidines; Pyridines; Small molecules
  • Mechanism of Action Histamine H2 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Duodenal ulcer; Peptic ulcer

Most Recent Events

  • 07 Aug 2007 Discontinued - Phase-III for Peptic ulcer in Japan (PO)
  • 07 Aug 2007 Discontinued - Phase-III for Duodenal ulcer in Japan (PO)
  • 24 Aug 2000 A study has been added to the pharmacodynamics section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top